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M protein is a  fibrillar molecule composed of two alpha-helical protein chains 
in a coiled-coil conformation extending from the surface of group A streptococci 
(1, 2). This molecule is the major virulence factor for the organism by virtue of 
its ability to render the bacterium resistant to phagocytosis in the human host 
(3).  Based on type-specific antigenic determinants on the M  molecule, approxi- 
mately 65  different serological M  types are currently recognized in nature.  In 
man, resistance to streptococcal infection appears to be the result of the presence 
of type-specific antibodies directed to the M  molecule which will neutralize its 
antiphagocytic properties (3). 
Previous investigations, which revealed very limited immunological crossreac- 
tions between purified M proteins of different serotypes, were primarily confined 
to detergent-extracted (4) or pepsin-extracted (5)  M  protein  fragments. These 
fragments comprise only the amino-terminal half of the M molecule (2, 6) and, 
thus, do not represent all of the determinants present on the native protein. 
Development of a vaccine to control streptococcal infections may depend upon 
the identification of a common M protein epitope with the ability to evoke cross- 
protective antibodies against multiple group A streptococcal serotypes. Since 56 
different M  serotyping strains show DNA homology with a  probe consisting of 
the  gene  for  the  M6  molecule,  a  common  region(s)  may exist  within  the  M 
proteins of different serotypes (7). 
In an attempt to identify the location of epitopes responsible for broad and 
limited crossreactivity among 56 of the currently known group A  streptococcal 
M serotypes, we have used monoclonal antibodies generated against phage lysin- 
extracted M6 protein, which comprises nearly the complete M molecule (8). Our 
results localize a  common (evolutionarily conserved) crossreactive epitope near 
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the middle of the M  molecule and an epitope of limited crossreactivity (evolu- 
tionarily divergent) in the amino-terminal half. 
Materials and Methods 
Bacterial Strains.  Group  A  streptococcal strains  from  The  Rockefeller University 
Culture Collection are the 56 representative strains used for serological differentiation of 
M types 1 through 67 in this laboratory (7) (strains D471  [type 6] and D472 [type 50] 
were used instead of the usual typing strains for these two M types). 
Plasmids.  pJRS42.13 encodes the entire structural gene for group A streptococcal M6 
protein  (8).  pJRS42.55  was  constructed  using  HindIII  to  delete  DNA  encoding the 
carboxy-terminal third (approximately) of the M6 protein (7). 
M6 Protein Preparations 
Isolation with Phage Lysin (LysM6).  M6 protein was isolated from streptococcal strain 
D471 using group C streptococcal phage-associated lysin and purified as described (9 and 
V. A. Fischetti, K. F. Jones, and B. N. Manjula, manuscript in preparation). 
Isolation from E. Coli (ColiM6).  M6 protein was purified from Escherichia coil containing 
pJRS42.13, as described by Fischetti et al. (6). 
Isolation with Pepsin (PepM6).  M6 protein was  isolated by limited pepsin extraction 
from strain D471 essentially by the method of Manjula and Fischetti (10). Crude PepM6 
was then dialyzed vs. 0.01  M Tris, pH 8.0, and applied to a  1 ml FPLC Mono Q column 
(Pharmacia Fine Chemicals, Piscataway, N  J) equilibrated in the same buffer. PepM6 was 
eluted by a 20 ml linear salt gradient from 0 to 0.06 M NaCI in 0.01  M Tris, pH 8.0, at 
2 ml/min. Pooled peak fractions were assayed both by sodium dodecyl sulfate-polyacryl- 
amide gel electrophoresis (SDS-PAGE) and immunoblot to determine purity. Amino acid 
sequence analysis  of the PepM6 fragment verified that it was from the amino-terminal 
half of the M6 molecule (6). 
Production and Purification of Monoclonal Antibodies.  LysM6 monoclonal antibodies 
were prepared from culture supernatants as described (6). 
SDS-PAGE and lmmunoblot Analysis.  Separation of proteins on  12%  SDS polyacryl- 
amide  gels  and  electrotransfer onto  nitrocellulose membranes  was  as  described  (6). 
Immunoblots were exposed to the appropriate monoclonal antibodies at an approximate 
concentration of 0.6 #g/ml and processed as described (6). 
Colony Blots.  Rabbit blood broth cultures of serotyping strains were streaked onto 
proteose peptone agar plates. After an 18-24 h incubation at 37 °C, colonies were overlaid 
with a nitrocellulose circle (0.45 #m; Schleicher and Schuell, Inc., Keene, NH) and allowed 
to adsorb for 5 min. The circle was removed from the agar surface, washed twice for 1 h 
each in 0.5% Tween 20 in 0.01 M phosphate-buffered saline (PBS), pH 7.4, and processed 
as immunobiots (6) using monoclonals at ~ 1.5 #g/ml. 
Whole Bacterial Cell, Enzyme-linked Immunosorbent  Assay (ELISA  ).  100 #1 of poly-L-lysine 
(100 #g/ml) in 0.01 M PBS, pH 7.2, was added to each well of a 96-well microtiter plate 
(Immulon II; Dynatech Laboratories, Inc., Alexandria, VA) for 1 h at room temperature. 
After excess poly-L-lysine was removed by suction, 50 #1 of PBS-washed streptococcal cells 
(5 ×  109 colony-forming units/ml in PBS) were added concurrently with 50 #1 of 0.2% 
glutaraldehyde in PBS. After incubation at room temperature for 20 rain, plates were 
centrifuged at  1,500 g for 20 min at 4°C. Wells were emptied by inversion and excess 
fluid removed by inverting plates onto blotting paper. After one wash  with PBS, plates 
were incubated for 1 h at room temperature with  100 #1 of 0.1  M lysine in PBS. Wells 
were again emptied, as above, washed once in PBS, and incubated 18 h at 4°C with 100 
#1 of 2%bovine serum albumin (BSA) in 0.01  M Tris, pH 7.5, with 0.02% sodium azide 
to block unbound sites.  Monoclonal antibodies at various concentrations (100 ~i in BSA) 
were incubated at 37°C for 3 h. Wells were emptied and washed three times with 0.1% 
BSA followed by an 18 h incubation at room temperature with 100 #1 of goat anti-mouse 
IgG alkaline phosphatase conjugate (Sigma Chemical Co., St.  Louis, MO). After three 
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FIGURE  1.  SDS-PAGE  and immunoblot analyses of the entire M6 molecule (ColiM6) and 
the amino-terminal M protein fragment (PepM6). M6 proteins were separated on 12% SDS 
polyacrylamide  gels and either stained with Coomassie  Blue or electroblotted onto nitrocellu- 
lose. lmmunoblots were processed with monOclonal  antibodies 10A 11 and 10B6 and visualized 
as described in Materials  and Methods. Molecular  weight standards (MW ads) are phosphoryt- 
ase b (94,000), bovine serum albumin (67,000), ovalbumin (43,000), carbonic anhydrase 
(30,000), and soybean trypsin inhibitor (20,100). 
was added at  1 mg/ml in  10%  diethanolamine, pH 9.8,  containing 1 mM magnesium 
chloride. After 30 min at 37°C, plates were read at 405 nm in a Titertek Muitiskan (Flow 
Laboratories, Inc., McLean, VA). 
Whole streptococcal cells were treated with pepsin after the 0.1  M lysine step.  Wells 
were washed twice with 0.1 M phosphate buffer, pH 5.8, and then incubated 1 h at 37 °C 
with 100 #1 of 200 #g/ml pepsin (Worthington Biochemical Corp., Freehold, N  J) in the 
same buffer. Digestion was stopped with 50 #1 of 1 M Trizma base, the wells were washed 
with PBS, blocked with BSA, and processed as above. 
Results 
Localization of the Epitopes of Two Monoclonal Antibodies Directed Against the M6 
Molecule.  SDS-PAGE and immunoblotting techniques were used to locate the 
binding sites of monoclonai antibodies prepared against LysM6 protein.  Mono- 
clonal antibodies  10A1 l/B11  (10A11)  and  10B6/G6  (10B6)  were selected for 
further studies on the basis of their immunoblot reactivity to the pepsin-extracted 
fragment of type 6  M  protein,  PepM6,  and to the entire  M  molecule isolated 
from E.  coli carrying  the  M6  protein  gene,  ColiM6,  as  illustrated  in  Fig.  1. 
Antibody  10A11  reacts  with  both  the  ColiM6  and  PepM6  molecules.  This 
localizes its epitope in the amino-terminal half of the M  molecule, distal to the 
cell  surface.  On  the  other  hand,  monoclonal  10B6  also  reacts  strongly  with 
ColiM6,  but  does  not  react  with  PepM6.  However,  by both  colony blot  and 
immunoblot analyses,  10B6 reacts with the truncated M6 molecule encoded by 
pJRS42.55,  which is deleted for the carboxy-terminal third (approximately) of 
the  native  molecule  (data  not  shown).  This  places  the  epitope  for  the  10B6 
antibody on the carboxy-terminal side of the pepsin cleavage site, near the center 
of the fibrous M6 molecule. ELISA of pepsin-digested whole streptococcal cells 
(data not shown) revealed the nearly complete loss of 10A11  reactivity, but no 
significant loss in reactivity for  10B6.  This suggests that the  10A11  epitope is 
not repeated in the carboxy half of the M6 molecule. 
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TABLE  I 
Reactions of M6 monoclonal antibodies IOA11 and 10B6 with Group A Streptococcal M 
Typing Strains,  as Determined by Colony Blots 
IOA11  10B6 
Strain  M type  Reactivity*  Strain  M type  Reactivity 
TSB/126/3  5  ++ 
D471  6  +++ 
T 14/46/3  14  + 
C 105/41/5  46  ++ 
C744/RB4/6/3  47  + 
A953/87/1  54  + 
B930/61/3  3  + 
T5B/126/3  5  +++ 
D471  6  ++ 
T12/126/2  12  + 
T 14/46/3  14  +++ 
T23/102/RB5  23  + 
C98/115/2  24  ++ 
D23  29  +++ 
D24/126/1  30  +++ 
J 137/69/2  31  +++ 
C121/39/3  32  ++ 
C119/83/1  36  ++ 
C 143/25/8  40  ++ 
C101/103/1  41  ++ 
C126/170/1  43  +++ 
C105/41/5  46  +++ 
C744/RB4/6/3  47  ++ 
A871/106/1  52  +++ 
A952/94/1  53  ++ 
A953/87/1  54  ++ 
A963  56  ++ 
* Reactions were scaled from +  to +++ (+++ represents the most intense reaction, using that between  10A 11 and 
M6 strain  D471  as the standard); reactions were termed negative when they displayed  no discernable reaction 
above conjugate control. 
epitopes  similar  to  those  present  on the  M6 protein  are  present  on  M  protein 
molecules of other streptococcal  M  serotypes,  we reacted  colony blots of group 
A  streptococcal  serotyping  strains with  10A11  and  10B6.  Table  I reveals  that 
10A11  crossreacted  with  five  non-M6  serotypes,  only  two  of which exhibited 
strong  reactions.  In  contrast,  10B6  demonstrated  a  much  higher  degree  of 
crossreactivity,  recognizing  similar  epitopes  within  20  different  M  serotypes. 
These crossreactions  were  further verified  to be directed  specifically  to the M 
molecule by immunoblot analysis of phage lysin-extracted  M proteins from each 
crossreacting  strain (V.  A.  Fischetti,  K.  F. Jones, and J. R.  Scott,  manuscript in 
preparation). 
Discussion 
Although hyperimmune rabbit sera prepared against whole streptococci  often 
exhibit limited  crossreactivity  with strains of different  M  serotypes  (4,  11-13), 
these antibodies rarely afford cross-protection  against strains of heterologous  M 
serotype.  Vaccines prepared  from purified, pepsin-extracted  M protein (PepM) 
fragments (representing the amino-terminal half of the molecule) (5), or synthetic 
peptides  therefrom  (14),  have  recently  been  observed  to exhibit limited  cross- 
reactivity and/or cross-protection  for only a small number of group A serotypes. 
In this investigation, monoclonal antibodies to LysM6, the protein comprising 
nearly the complete  M6 molecule,  demonstrated  more extensive crossreactivity 
among different group A streptococcal  M serotypes.  On colony blots, antibodies 
10A11  and 10B6 crossreacted  with 5 and 20, respectively,  of the 56 different M 
serotypes  examined.  The  specificities  of the  limited  crossreactions  of  10A11 
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M6 protein (an amino-terminal  fragment analogous to the pepsin-derived mole- 
cule [6,  15]) reacted with a limited number of unabsorbed hyperimmune rabbit 
typing sera (prepared against whole streptococcal cells) in a radioimmunoassay. 
This suggests that the 10A 1 I-reactive epitope may be one of the major antigenic 
determinants  within the amino-terminal  region of the M molecule. Also, all the 
10A 11-reactive M  types are also reactive with  10B6. Since these M types share 
two epitopes, they may be more closely related  evolutionarily than  those with 
only one epitope in common. 
Immunobiot analysis of the ColiM6 and PepM6 molecules with monoclonals 
10A 11 and  10B6 (Fig.  1) shows that a conserved crossreactive epitope is located 
near  the  middle  of the  M  molecule and  a  less common  crossreactive epitope 
resides  in  the  amino-terminal  half.  Since  the amino-terminal  region  of the  M 
protein  is  distal  to  the  streptococcal cell  surface  (6),  by virtue  of its  ~600  ,~ 
fibrous structure  (2),  it  may be more exposed to the environment.  Thus,  this 
region may be more accessible to the host's immune  surveillance system.  One 
would then  expect this  region  of the  molecule to evolve faster in  response to 
immunological  selection and  therefore display greater antigenic  variability be- 
tween serotypes than a  more ceil-proximal  region of the molecule. This expec- 
tation appears to have been borne out by amino acid sequence comparisons of 
M proteins (16) as well as by the current finding that monocional  10A11 (which 
has  an  amino-terminal  epitope)  reacts  with  fewer  serologically  different  M 
molecules than does 10B6, whose epitope is more centrally located. Perhaps the 
latter  epitope  is  more  conserved  among  serologicaily  different  M  proteins, 
because  of its  closer  proximity  to  the  cell  surface,  and  is  thus  less  likely  to 
encounter vigorous immunological pressures. 
We are currently investigating whether there is a sequence conserved among 
all M types, which would be consistent with DNA hybridization results (7). The 
strong  binding  of monoclonal  10B6  to  intact  cells  (detected by colony blots) 
indicates that when the M molecule is in its native state on the cell surface, this 
crossreactive site is not sequestered from antibody attachment despite its central 
location on the molecule. Taking advantage of the accessibility to the immune 
system  of such  conserved  determinants  may  enable  us  to  devise  methods  to 
stimulate a cross-protective antibody response to a large number of streptococcal 
M serotypes. 
Summary 
In  studies  primarily  confined  to  the  amino-terminal  region  of the  fibrillar 
group A streptococcal M protein, only limited immunological crossreactions have 
been observed among  M  serotypes.  In  this investigation,  two monoclonal anti- 
bodies generated  against nearly the entire  M6 molecule (LysM6) were used to 
determine the extent of crossreactions among M serotyping strains and to localize 
their epitopes on the M molecule. Colony blot and immunoblot analyses revealed 
that  an  epitope  responsible  for  crossreactions  among  5  of the  56  strains  of 
different M serotypes tested is located in the amino-terminal half of the molecule, 
distal  to  the  cell  surface.  In  contrast,  a  more  common  crossreactive  epitope, 
reacting with 20 of the 56 strains, is located near the middle of the M molecule. 
These  studies also reveal  that  the  more conserved determinant,  located more 
proximally to the cell surface, is accessible to the immune system, even on the 628  JONES  ET  AL.  BRIEF  DEFINITIVE REPORT 
whole organism, and, thus, may be useful in devising means to protect against 
infections by multiple group A streptococcal M serotypes. 
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